Protection of human research subjects has recently emerged as a major ethical and legal issue following the death of subjects involved in gene therapy and other research. The symposium is intended for individuals engaged in basic, clinical, educational and behavioral research involving human subjects.
Topics: Two core presentations will be given: "IRB 101: Evolution of IRBs Charge and Standard Operation Procedure" and "The Duke Experience: What Lessons Can IRBs Learn?" Other "hot" topics to be discussed in workshop formats include gene therapy, research on human tissue specimens, competency to give informed consent, adverse event reporting, placebo effects, continuing review and monitoring of ongoing research and pediatric and clinical trials.
Who: Symposium faculty is comprised of:
o Marian P. Cailaghan, M.D., St. Christopher's Hospital for Children
o Jeffrey M. Cohen, Ph.D., Office for the Protection of Research Risks, NIH
o Jeffrey A. Cooper, M.D., Albany (N.Y.) Medical Center
o Bonnie Lee, Food and Drug Administration
o Robert J. Levine, M.D., Yale University School of Medicine
o Victor M. Lidz, Ph.D., MCP Hahnemann University
o Jeremy Sugarman, M.D., M.P.H., M.A., Duke Univ. School of Medicine
When: Wednesday, May 31, 2000, from 8:30 a.m. through 5 p.m.
Where: MCP Hahnemann University's New College Building in Geary Auditorium (245 North 15th Street)
On-site
Contact: Dr. Sreekant Murthy, Associate Vice President for Regulatory Compliance, MCP Hahnemann University
News Media
Contact: To attend the symposium or arrange interviews with the symposium faculty, contact Kevin C. Kaufman at the Drexel News Bureau at 215/895-2705 or [email protected].
# # #
RSS